home / stock / dxr / dxr news

DXR News and Press, Daxor Corporation From 06/27/22

Stock Information
Company Name: Daxor Corporation
Stock Symbol: DXR
Market: NYSE
Website: daxor.com
Menu
DXR DXR Quote DXR Short DXR News DXR Articles DXR Message Board
Get DXR Alerts

News, Short Squeeze, Breakout and More Instantly...
DXR - DAXOR ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT PHASE II AGREEMENT WITH THE UNIFORMED ARMED SERVICES UNIVERSITY FOR THE DEVELOPMENT OF A NON-NUCLEAR BLOOD VOLUME ANALYSIS (BVA) DEVICE

New BVA Device Aims to Possess Gold Standard Accuracy and Reproducibility with Increased Safety, Access, Ease of Use, and Frequency of Testing Afforded by a Non-Nuclear Tracer Oak Ridge, TN, June 27, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the g...
DXR - Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 18th Annual Meeting

Oak Ridge, TN, June 13, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 18 th Annual Meeting from J...

DXR - Daxor's Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of "Long Hauler" COVID-19 Patients

Oak Ridge, TN, May 25, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today participation in the National Institutes of Health (NIH) Intramural Research Program-sponsored study titled “An Obser...

DXR - Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference

NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will present at the H.C. Wainwright Global Life Investment Hybrid Conference which i...
DXR - New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

Study Presented at the International Society for Heart and Lung Transplant 42 nd Annual Meeting and Scientific Sessions 2022 Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...

DXR - Daxor blood volume test BVA-100 shows accuracy for heart condition in new study

Daxor (NASDAQ:DXR) said new data for its BVA-100 test showed the system was uniquely able to measure the intravascular congestion of heart failure patients, a key metric that is targeted to improve their outcomes. The new study from Duke Heart, which was presented at the 71st Annual Amer...

DXR - New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor's Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure

Study Presented at the 71st Annual American College of Cardiology Meeting Oak Ridge, TN, April 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume measurement technology, today announces new data from Duke ...
DXR - Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference

Oak Ridge, TN, March 23, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume measurement technology, announces that President and CEO Michael Feldschuh will present at Maxim Group 2022 Virtual Growth Conference ...

DXR - Daxor reports FY results

Daxor press release (NASDAQ:DXR): FY NAV of $5.24 per share versus $3.89 in FY 2020. For further details see: Daxor reports FY results

DXR - Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fiscal 2021

Revenues of Operating Division Increase by 70 . 6 % Oak Ridge, TN, March 01, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume measurement technology, filed its Annual Report to Shareholders o...
Previous 10 Next 10